Three Food and Drug Administration advisory committees voted on sweeping changes regarding the marketing, merchandising and formulation of acetaminophen products last month, though the proposed changes fell short of pulling combination products containing acetaminophen off the market. This ECRM section covers intricacies of the FDA committees' decision, as well as external analgesics, foot care, PSE regulations and baby care.
When the going gets tough, the tough look for new ways to serve patients. Over the past year, the growing healthcare funding crisis and the worst economic climate since the 1930s have spawned competing health-reform proposals in Washington and cast a cloud of uncertainty over the U.S. health system, including community pharmacy. But they also have unleashed a flurry of retail innovation in such areas as pharmacy-based care, medication therapy management and patient compliance initiatives.